Venneos
Venneos develops and markets the ‘CAN-Q‘, a silicon-chip-based imaging system for the label-free analysis of biological cells. Venneos’ products build upon an innovative measurement approach that allows customers to see cellular changes which stay invisible with other technologies. Experiments become more objective, reproducible and reliable. The microscopy-like visualization of the results enables an intuitive interpretation.
Researchers in areas such as tumor biology, immunology and pharmacology as well as pharma and biotech companies are among its pilot customers.
Founded in: 2014
CDTM Founders: David Wehner, Jonas Lehmann
From the CDTM classes: Fall 2009, Fall 2011
